Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Latest filing published 26 May 2026 for Bausch Health Companies Inc..
Filing timeline
BuySaleMichael Goettler
Insider track record
Disclosed buys
1
Disclosed sells
4
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -8.6%Entry US$10.39 · Close at T+365 US$9.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michael Goettler: trading record in brief
On August 1, 2018, Michael Goettler made 3 sales on the same day at Pfizer Inc (listed as Group President): EUR 372,816, EUR 113,692 and EUR 112,302. With a fourth, the record counts 4 sales worth EUR 653,286 in total, with a median of EUR 112,997. Pfizer accounts for 22 filings.
The only purchase came later and is larger than any single sale, at EUR 453,956 on March 15, 2022 at Viatris Inc, where the listed role is Chief Executive Officer (25 filings). It is 20% of the market trades. Bausch Health Companies Inc. adds 2 filings, with the role Director.
In all there are 49 filings, with 28 grants and 16 option exercises. By year: 4 in 2018, 9 in 2019, 9 in 2020, 11 in 2022, 12 in 2023, then 1 in 2025 and 1 in 2026. The last twelve months hold 1 filing, with no purchase and no sale. The median publication delay is 2 days. Goettler's own market trades within 30 days of colleagues at Pfizer Inc number 4, 4 and 4. Every one in the same direction. Colleagues in order: Alexander R. Mackenzie, Frank A. Damelio and Ian C. Read.
Companies and markets linked to Michael Goettler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations49 total
45,871 shares0Common Shares, No Par ValueSEC:0000885590-26-000076:0
30,149 shares0Common Shares, No Par ValueSEC:0001127602-25-019741:0
37,173 shares@ US$11.1315.0% of flowCommon StockSEC:0000899243-23-007213:1
45,569 shares@ US$11.1318.5% of flowCommon StockSEC:0000899243-23-007213:5
1,639 shares@ US$11.130.7% of flowCommon StockSEC:0000899243-23-007213:7
6,715 shares0Common StockSEC:0000899243-23-007213:2
2,940 shares@ US$11.131.2% of flowCommon StockSEC:0000899243-23-007213:3
104,085 shares0Common StockSEC:0000899243-23-007213:4
3,742 shares0Common StockSEC:0000899243-23-007213:6
84,908 shares0Common StockSEC:0000899243-23-007213:0
52,526 shares@ US$11.2021.6% of flowCommon StockSEC:0000950170-23-005641:1
3,833 shares@ US$11.201.6% of flowCommon StockSEC:0000950170-23-005641:3
8,753 shares0Common StockSEC:0000950170-23-005641:2
119,975 shares0Common StockSEC:0000950170-23-005641:0
280 shares@ US$10.390.1% of flowCommon StockSEC:0000899243-22-011989:1
639 shares0Common StockSEC:0000899243-22-011989:0
50,352 shares@ US$9.866100.0% of flowCommon StockSEC:0000899243-22-011133:0
Canonical exit: 13 Jun 2022 (T+90)
883 shares@ US$10.480.3% of flowCommon StockSEC:0000899243-22-009570:3
36,918 shares@ US$10.4813.5% of flowCommon StockSEC:0000899243-22-009570:1
2,030 shares0Common StockSEC:0000899243-22-009570:2
84,908 shares0Common StockSEC:0000899243-22-009570:0
23,461 shares@ US$11.019.0% of flowCommon StockSEC:0000899243-22-008661:1
561 shares@ US$11.010.2% of flowCommon StockSEC:0000899243-22-008661:3
1,290 shares0Common StockSEC:0000899243-22-008661:2
53,958 shares0Common StockSEC:0000899243-22-008661:0
25 of 49 declarations
